《美股》聚焦英偉達季績及儲局風波 美三大股指表現平淡 英偉達靠穩
投資者聚焦晶片龍頭英偉達(NVDA.US)即將公布的季度業績,同時消化美國總統特朗普罕見撤換聯儲局理事庫克的消息,美股周二表現平淡,標普500指數與道指基本持平,納指則跌0.2%。
英偉達宣布推出「機械人大腦」晶片,售價3,499美元,股價微升0.2%。
特朗普政府考慮入股Lockheed Martin(LMT.US)等國防承包商,該股早段跑贏大市,升逾1%。
AT&T(T.US)擬斥資230億美元向EchoStar(SATS.US)購買部分頻譜許可,後者股價升76%,創52周新高。AT&T持平。
特朗普撤換庫克的決定或最終進入司法挑戰。按法律規定,總統僅能在有合理原因下撤換聯儲局理事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.